Ascendis Pharma A (ASND) FCF Margin (QoQ) (2014 - 2026)

Ascendis Pharma A (ASND) FCF Margin (QoQ) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Ascendis Pharma A 15.31 Bn 14.64 Bn 268.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2,239.00
Dec 31, 2025 -2,653.00
Sep 30, 2025 565.00
Jun 30, 2025 953.00
Mar 31, 2025 1,395.00
Dec 31, 2024 6,813.00
Sep 30, 2024 7,311.00
Jun 30, 2024 -6,364.00
Mar 31, 2024 -9,167.00
Dec 31, 2023 24,356.00
Sep 30, 2023 6,455.00
Jun 30, 2023 11,238.00
Mar 31, 2023 16,330.00
Dec 31, 2022 2,786.00
Sep 30, 2022 133,318.00
Jun 30, 2022 -9,933.00
Mar 31, 2022 -166,458.00
Dec 31, 2021 755,157.00
Sep 30, 2021 317,508.00
Jun 30, 2021 -52,028.00